company background image
CPCI logo

Kahira Pharmaceuticals & Chemical Industries CASE:CPCI Stock Report

Last Price

ج.م79.95

Market Cap

ج.م1.2b

7D

-2.0%

1Y

108.2%

Updated

25 Feb, 2024

Data

Company Financials

Kahira Pharmaceuticals & Chemical Industries Company

CASE:CPCI Stock Report

Market Cap: ج.م1.2b

CPCI Stock Overview

Kahira Pharmaceuticals & Chemical Industries Company engages in the manufacturing and sale of pharmaceuticals, medical preparations, cosmetics, and materials in Egypt.

CPCI fundamental analysis
Snowflake Score
Valuation1/6
Future Growth0/6
Past Performance2/6
Financial Health5/6
Dividends5/6

Kahira Pharmaceuticals & Chemical Industries Company Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Kahira Pharmaceuticals & Chemical Industries
Historical stock prices
Current Share Priceج.م79.95
52 Week Highج.م82.58
52 Week Lowج.م34.22
Beta0.089
1 Month Change28.35%
3 Month Change24.73%
1 Year Change108.20%
3 Year Change101.13%
5 Year Change144.05%
Change since IPO117.61%

Recent News & Updates

Recent updates

Shareholder Returns

CPCIEG PharmaceuticalsEG Market
7D-2.0%2.3%2.1%
1Y108.2%50.9%89.0%

Return vs Industry: CPCI exceeded the EG Pharmaceuticals industry which returned 50.9% over the past year.

Return vs Market: CPCI exceeded the EG Market which returned 89% over the past year.

Price Volatility

Is CPCI's price volatile compared to industry and market?
CPCI volatility
CPCI Average Weekly Movement6.6%
Pharmaceuticals Industry Average Movement5.7%
Market Average Movement7.6%
10% most volatile stocks in EG Market11.2%
10% least volatile stocks in EG Market4.9%

Stable Share Price: CPCI's share price has been volatile over the past 3 months.

Volatility Over Time: CPCI's weekly volatility (7%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
19622,001Yasser Farghalihttps://www.kahirapharma.com

Kahira Pharmaceuticals & Chemical Industries Company engages in the manufacturing and sale of pharmaceuticals, medical preparations, cosmetics, and materials in Egypt. The company is involved in the provision of chemicals, extracts, veterinary medicines, and pesticides; and packaging and distribution activities. It also exports its products to Iraq, Yemen, Sudan, Somalia, Jordan, Libya, Senegal, Zimbabwe, South Sudan, Mali, and Kenya.

Kahira Pharmaceuticals & Chemical Industries Company Fundamentals Summary

How do Kahira Pharmaceuticals & Chemical Industries's earnings and revenue compare to its market cap?
CPCI fundamental statistics
Market capج.م1.19b
Earnings (TTM)ج.م117.47m
Revenue (TTM)ج.م1.09b

10.2x

P/E Ratio

1.1x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
CPCI income statement (TTM)
Revenueج.م1.09b
Cost of Revenueج.م820.72m
Gross Profitج.م267.74m
Other Expensesج.م150.27m
Earningsج.م117.47m

Last Reported Earnings

Sep 30, 2023

Next Earnings Date

n/a

Earnings per share (EPS)7.87
Gross Margin24.60%
Net Profit Margin10.79%
Debt/Equity Ratio24.7%

How did CPCI perform over the long term?

See historical performance and comparison

Dividends

6.3%

Current Dividend Yield

64%

Payout Ratio
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.